CORTROSYN

This brand name is authorized in Canada, Japan, United States

Active ingredients

The drug CORTROSYN contains one active pharmaceutical ingredient (API):

1 Tetracosactide UNII 72YY86EA29 - COSYNTROPIN

Tetracosactide acetate consists of the first 24 amino acids occurring in the natural corticotropic hormone (ACTH) sequence and displays the same physiological properties as ACTH. In the adrenal cortex, it stimulates the biosynthesis of glucocorticoids, mineralocorticoids, and, to a lesser extent, androgens, which explains its therapeutic effect in conditions responsive to glucocorticoid treatment. Read about Tetracosactide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CORTROSYN Powder for solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01AA02	Tetracosactide	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AA ACTH
Discover more medicines within H01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00022381
Country: JP	医薬品医療機器総合機構	Identifier(s): 2411400D2029, 2411401A3023
Country: US	FDA, National Drug Code	Identifier(s): 0548-5900, 50090-4547, 52584-050